Patients' access to medical marijuana has dramatically increased despite the lack of Food and Drug Administration approval. In this study, we profiled individuals and the conditions for which they were certified for medical marijuana, and we examined the evidence of coordination with their physicians providing traditional care. Within two years of initiation, medical marijuana was approved for 3.4 percent of Arkansans ages eighteen and older by 12.5 percent of physicians who had an active license in the state. Posttraumatic stress disorder and four pain diagnoses were the most frequent qualifying conditions. We observed care coordination among low-volume certifying physicians, with a majority having both seen and diagnosed the adult with the qualifying conditions. Conversely, seven high-volume certifying physicians, each with more than 1,000 certifications, demonstrated limited contact with those they certified. The Department of Health and Human Services has recommended that marijuana be changed from Schedule I to Schedule III in the Controlled Substances Act, and the Justice Department has submitted a notice of proposed rulemaking to effect this change. Implications include the need to continue research and develop clinical guidelines, notify routine providers of care with potential incorporation of certifications into the health information exchanges, and consider screening for medical marijuana use in clinical settings.

Download full-text PDF

Source
http://dx.doi.org/10.1377/hlthaff.2024.00380DOI Listing

Publication Analysis

Top Keywords

medical marijuana
20
care coordination
8
qualifying conditions
8
certifying physicians
8
marijuana
6
physicians
5
arkansas medical
4
marijuana certifications
4
certifications higher-volume
4
higher-volume physicians
4

Similar Publications

The prevalence and characterisation of energy drink consumption in North America: A systematic review.

Public Health

March 2025

Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.

Objectives: Energy drinks (ED), which contain high levels of caffeine, are widely popular and their consumption is increasing, especially among young people who may have limited understanding of the associated risks. The aim of this study was to identify the prevalence of ED consumption in North America (Canada, Mexico and the US) and to characterise ED consumers.

Study Design: Systematic review.

View Article and Find Full Text PDF

Background: The trends of recreational use of cannabis and the use of cannabis for medical indications (i.e., "medical cannabis") have grown in recent years.

View Article and Find Full Text PDF

Background: Our objective was to provide an overview of the currently available scientific and clinical data supporting the use of and -derived products for the treatment of chronic pain disorders. We also provide information for researchers, clinicians, and patients to be better informed and understand the approach behind the recommendation of as a potential adjuvant in the treatment/control of chronic pain. Cannabis and its bioactive compounds have sparked interest in the field of pain treatment in spite of its controversial history and status as a controlled substance in many countries.

View Article and Find Full Text PDF

Detecting and understanding potential stigma among medical cannabis users in Germany.

BMC Public Health

March 2025

Department of the History, Philosophy and Ethics of Medicine, Centre for Health and Society, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.

Background: Despite its increasing prevalence among the public, cannabis use is still perceived as deviant behavior and consequently stigmatized. However, there remains a paucity of understanding regarding the impact of this stigma on patients employing cannabis for therapeutic purposes. This qualitative research endeavored to explore the stigma experiences of medical cannabis (MC) users in Germany, aiming to discern challenges that may impede their daily lives and healthcare access.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!